Exclusive access to the eMed GLP-1 Program

eMed is proud to offer Disney a behind-the-scenes look at the GLP-1 Program. FDA-approved, branded medications inside a structured program guided by licensed clinicians.

Access code VIPACCESS

PROVEN OUTCOMES

Industry leading adherence. Real results. Measured from day one.

+90
%

GLP-1 program adherence rate

96
%

Reduction in prediabetes risk

Among members with HbA1C > 5.7% at enrollment

-25
lbs

Average weight lost per member

Starting average: 215 lbs

eMed is proud to offer Disney VIPs

Exclusive pricing on GLP-1 medications

eMed Program Access

Included

Your program membership is covered. If you qualify for medication, exclusive pricing is available below.

Access code VIPACCESS

You’ve got GLP-1 coverage challenges. eMed has solutions.

Our program takes on the biggest challenges in GLP-1 coverage: inflated pricing, access barriers, low adherence, and poor outcomes.

Lower Cost

Reduce clinical cost of care and get direct pricing on FDA-approved medications with no PBM markups, no rebate inflation and no surprises.

More Control

You set the employee contribution. You manage utilization. You own the outcome.

High Adherence

At-home diagnostics, 24/7 support and ongoing progress tracking keeps members coming back.

Guaranteed Outcomes

We guarantee employee weight loss and adherence. If we miss, you pay less.

01

Start Your Journey

Member enrolls via eMed app and receives a screening kit

02

Guided Medical Intake

A complete, clinician-guided intake — all from home.

03

Clinical Review & Delivery

Interactive clinical evaluation & results

04

Weekly Check-Ins

Helping users stay on track — every week, every step.

05

Seamless Monthly Refill Process

Users can manage their refill timing or consult FAQs.

06

Continuous Progress Monitoring

A running summary of health status and improvements — all in one place.

Special pricing for GLP-1 Medication

Medication details
eMed price*
ZepBound 2.5 insulin pen injector with gray body and purple cap on white background.
Zepbound
KwikPen® (1-month supply)
2.5 mg (Starting dose)
$299
Close-up of a gray medical injector pen with a purple cap and a small display window.
Zepbound
KwikPen® (1-month supply)
5 mg (Starting dose)
$399
Close-up of a gray medical injector pen with a purple cap and a small display window.
Zepbound
KwikPen® (1-month supply)
7.5mg, 10mg, 12.5mg, 15mg
$449
Wegovy Pen 0.25 mg for subcutaneous injection on a white background.
Wegovy® Pen
4 single-use pens (1-month supply)
0.25 mg and 0.5 mg
$199
Wegovy pen for injectable medication with dosage window on white background.
Wegovy® Pen
4 single-use pens (1-month supply)
1 mg, 1.7 mg, 2.4 mg
$349*
Wegovy injectable medication pen with purple label on a light background.
Wegovy® Pen
4 single-use pens (1-month supply)
7.2 mg
$399

*Offer valid for the first 2 months (new patients only) through June 30, 2026, then $349/month

Bottle of Wegovy 2.4 mg injectable solution with a white cap and blue text on a white label.
Wegovy® Pills
Oral tablets (30-day supply)
1.5 mg and 4 mg
$149*
Bottle of Wegovy 2.4 mg injection pens for weekly diabetes treatment on white background.
Wegovy® Pills
Oral tablets (30-day supply)
9 mg and 25 mg
$299

*4 mg offer valid through August 31, 2026, then $199/month

Prices reflect self-pay pricing for eligible eMed members. Prescription required. Pricing and availability subject to change. Eligibility restrictions may apply.

For complete safety and efficacy information, please review the Full Prescribing Information for each product:
Wegovy® Prescribing Information and Medication Guide
Zepbound® Prescribing Information and Medication Guide
Wegovy and Zepbound may cause serious side effects, including:
•Possible thyroid tumors, including cancer.
Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Wegovy, Zepbound, and medicines that work like them caused thyroid tumors, including thyroid cancer. It is not known if Wegovy or Zepbound will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
•Do not use Wegovy or Zepbound if you or any of your family have ever had a type of thyroid cancer called medullary thryoid carcinoma (MTC), or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).


See Indication and Important Safety Information here.

Access the eMed GLP-1 Program

Your journey begins here.